Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium valproate versus cinnarizine in children with migraine
IRCT20251123068096N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of valproic acid and cinnarizine in migraine (2 arms), sponsored by Yasouj University of Medical Sciences. Primary endpoints: Quality of life, Sleepiness and 3 more. Started Jan 2026; status: completed.
02
Drugs
valproic acidcinnarizine
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20251123068096N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251123068096N1.